Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$774K Sell
5,250
-2,890
-36% -$423K 0.05% 203
2025
Q4
$990K Buy
8,140
+790
+11% +$92.7K 0.06% 185
2025
Q3
$793K Sell
7,350
-190
-3% -$17.7K 0.05% 223
2025
Q2
$675K Buy
7,540
+550
+8% +$41.4K 0.04% 237
2025
Q1
$475K Buy
6,990
+600
+9% +$43.2K 0.04% 265
2024
Q4
$403K Buy
6,390
+1,290
+25% +$87.2K 0.03% 272
2024
Q3
$395K Sell
5,100
-80
-2% -$6.28K 0.03% 282
2024
Q2
$411K Buy
5,180
+750
+17% +$55.4K 0.04% 268
2024
Q1
$309K Sell
4,430
-20
-0.4% -$1.28K 0.03% 278
2023
Q4
$258K Buy
+4,450
New +$232K 0.03% 289

Other funds holding KLAC

Keel Point's KLAC Position: Q1 2026 in Review

Keel Point reduced its KLA (KLAC) stake by 36% in Q1 2026, selling an estimated $423K and leaving 5,250 shares worth $774K. The position accounts for 0.05% of the portfolio, ranked #203.

Keel Point first reported a position in KLAC in Q4 2023 and has held it in 10 quarters since. The position peaked at $990K in Q4 2025. 2,063 funds tracked by Wall St. Rank hold KLAC as of Q1 2026.

  • Keel Point held 5,250 shares of KLA worth $774K as of Q1 2026.
  • Keel Point sold 2,890 KLA shares in Q1 2026, an estimated $423K.
  • KLA made up 0.05% of Keel Point's portfolio in Q1 2026, its #203 holding.
  • Keel Point first reported a position in KLA in Q4 2023 and has held it in 10 quarters since.
  • Keel Point's KLA position peaked at $990K in Q4 2025.
  • 2,063 funds tracked by Wall St. Rank held KLA as of Q1 2026.

Based on Keel Point's 13F filing for Q1 2026, filed 1 Jun 2026.